{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:51:01Z","timestamp":1762905061099,"version":"3.45.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ajogmf.2020.100166","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T11:57:09Z","timestamp":1593086229000},"page":"100166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth"],"prefix":"10.1016","volume":"2","author":[{"given":"Alexandra M.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Mikovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia B.","family":"Forinash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Babbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2020.100166_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2471\/BLT.08.062554","article-title":"The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity","volume":"88","author":"Beck","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ajogmf.2020.100166_bib5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/AOG.0b013e3182723b1b","article-title":"Practice bulletin no. 130: prediction and prevention of preterm birth","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib6","doi-asserted-by":"crossref","first-page":"131.e1","DOI":"10.1016\/j.ajog.2013.09.014","article-title":"The NICHD Consecutive Pregnancies Study: recurrent preterm delivery by subtype","volume":"210","author":"Laughon","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib7","doi-asserted-by":"crossref","first-page":"576.e1","DOI":"10.1016\/j.ajog.2007.01.039","article-title":"Recurrence risk for preterm delivery","volume":"196","author":"McManemy","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.AOG.0000275287.08520.4a","article-title":"Prediction and prevention of recurrent spontaneous preterm birth","volume":"110","author":"Spong","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/1471-0528.12182","article-title":"Risk factors for recurrent preterm birth in multiparous Utah women: a historical cohort study","volume":"120","author":"Simonsen","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2020.100166_bib10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1056\/NEJM200201243460412","article-title":"Predicting premature delivery\u2014no easy task","volume":"346","author":"Lockwood","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100166_bib11","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100166_bib12","doi-asserted-by":"crossref","first-page":"B11","DOI":"10.1016\/j.ajog.2017.01.022","article-title":"The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth","volume":"216","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib13","doi-asserted-by":"crossref","first-page":"600.e1","DOI":"10.1016\/j.ajog.2017.02.025","article-title":"17-Alpha hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study","volume":"216","author":"Nelson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib14","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1080\/14767058.2016.1269164","article-title":"Effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alpha-hydroxyprogesterone caproate injections","volume":"30","author":"Haidar","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2020.100166_bib15","doi-asserted-by":"crossref","first-page":"224.e1","DOI":"10.1016\/j.ajog.2007.01.002","article-title":"Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Rebarber","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0039-3400227","article-title":"17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): a multicenter, international, randomized double-blind trial","volume":"37","author":"Blackwell","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0039-1678532","article-title":"Factors associated with utilization of 17-hydroxyprogesterone caproate for the prevention of recurrent preterm birth","volume":"37","author":"DeNoble","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib18","doi-asserted-by":"crossref","first-page":"105.e1","DOI":"10.1016\/j.ajog.2016.01.180","article-title":"17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: a retrospective cohort study","volume":"215","author":"Stringer","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/biores.2019.0010","article-title":"Improving uptake and adherence to 17-hydroxyprogesterone caproate in non-Hispanic black women: a mixed methods study of potential interventions from the patient perspective","volume":"8","author":"Wheeler","year":"2019","journal-title":"Biores Open Access"},{"key":"10.1016\/j.ajogmf.2020.100166_bib20","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2015.12.054","article-title":"Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth","volume":"214","author":"Yee","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015402","article-title":"Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis","volume":"7","author":"Phillips","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajogmf.2020.100166_bib22","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2010.03.023","article-title":"17 Alpha-hydroxyprogesterone caproate vehicle, castor oil, enhances the contractile effect of oxytocin in human myometrium in pregnancy","volume":"202","author":"O\u2019Sullivan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100166_bib23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/bmj.1.5130.1162","article-title":"Effect of castor oil, soap enema, and hot bath on the pregnant human uterus near term; a tocographic study","volume":"1","author":"Mathie","year":"1959","journal-title":"Br Med J"},{"key":"10.1016\/j.ajogmf.2020.100166_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jamainternmed.2017.5017","article-title":"Utilization, cost, and outcome of branded vs compounded 17-alpha hydroxyprogesterone caproate in the prevention of preterm birth","volume":"177","author":"Fried","year":"2017","journal-title":"JAMA Intern Med"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:46:31Z","timestamp":1762904791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933320301105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2589933320301105"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100166","relation":{},"ISSN":["2589-9333"],"issn-type":[{"type":"print","value":"2589-9333"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100166"}}